Jennifer Jarrett

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

• Identityunclaimed
  Published
• Evidencecorroborated
  Published
• Evaluationnot_evaluated
  Published
• MonitoringNot yet published for this record.
  Not published
• AuthorityNot yet published for this record.
  Not published
• Freshnesscurrent
  Published

Seats held as a director, as published in the cited sources.

1. Current · dates not published
   President and Chief Executive OfficerDamora Therapeutics, Inc.
   E3
2. 2026 to end not published
   Executive title: President, Chief Executive Officer and DirectorOrganization not published
   E2E1
3. Dates not published
   Executive title: Chief Operating OfficerOrganization not published
   E6
4. Dates not published
   Executive title: President and Chief Executive OfficerOrganization not published
   E3

No education, credentials, or certifications are published in this record.

Who may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

• Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
• Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
• Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
• Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.

Each relationship is one Claim rendered on every record it connects.

• SB
  Sagimet Biosciences Inc.Director, 2024 to present
  person:jennifer-jarrett-2:role:1
• ZB
  Zura Bio LtdDirector, 2023 to present
  person:jennifer-jarrett-2:role:2
• DT
  Damora Therapeutics, Inc.President, Chief Executive Officer and Director, Current · dates not published; President and Chief Executive Officer, Current · dates not published
  person:jennifer-jarrett-2:role:4, person:jennifer-jarrett-2:role:3
• ON
  Organization not publishedExecutive title: President, Chief Executive Officer and Director, 2026 to end not published; Executive title: Chief Operating Officer, Dates not published; Executive title: President and Chief Executive Officer, Dates not published
  person:jennifer-jarrett-2:executive_title:13, person:jennifer-jarrett-2:executive_title:11 +1

This record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.

Basis

Public role at an organization in the published Registry

Sources

10 evidence records cited. 0 with redistribution rights.

Never published

Home address, family, personal contacts, health, and history unrelated to the public role

Profile claimed

No

Open disputes

0

Identity ownership

unclaimed

If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.

1. E1
   GLTO DEF 14A executive officers

   SEC EDGAR. sec filing. Published Apr 29, 2026. Retrieved Jul 28, 2026. Cited by 5 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
2. E2
   DMRA DEF 14A executive officers

   SEC EDGAR. sec filing. Published Apr 29, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
3. E3
   Source title not published

   sec def 14a. Published Apr 29, 2026. Retrieved Sep 6, 2026. Cited by 3 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
4. E4
   SGMT DEF 14A director slate

   SEC EDGAR. sec filing. Published Apr 21, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
5. E5
   Source title not published

   sec proxy. Published Apr 21, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
6. E6
   ZURA DEF 14A director slate

   SEC EDGAR. sec filing. Published Apr 23, 2025. Retrieved May 16, 2026. Cited by 7 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
7. E7
   Source title not published

   sec proxy. Published Apr 23, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
8. E8
   Source title not published

   public source. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
9. E9
   Source title not published

   public source. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
10. E10
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

• Jennifer Jarrett seat on Sagimet Biosciences Inc., effective 2024-01-01.
• Jennifer Jarrett seat on Zura Bio Ltd, effective 2023-01-01.